Zoetis (ZTS) Enterprise Value (2012 - 2026)
Zoetis' (ZTS) quarterly Enterprise Value came in at -$1.9 billion in Q1 2026, down 12.78% year-on-year from -$2.2 billion in Q1 2025, and up 20.78% on a QoQ basis from -$2.4 billion in Q4 2025.
Zoetis (ZTS) Enterprise Value (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Enterprise Value data on file, last reported at -$1.9 billion in Q1 2026.
- On a quarterly basis, Enterprise Value fell 12.78% year-over-year to -$1.9 billion in Q1 2026; TTM through Mar 2026 was -$1.9 billion, a 12.78% decrease from a year earlier, with the FY2025 full-year figure at -$2.4 billion, down 23.3% from the prior year.
- Enterprise Value for Q1 2026 stood at -$1.9 billion, up from -$2.4 billion in the prior quarter.
- Over the last five years, Enterprise Value for ZTS reached as high as -$1.4 billion in Q2 2025 and fell as low as -$3.6 billion in Q4 2022.
- Historically, Enterprise Value has averaged -$2.1 billion across 5 years, with a median of -$2.0 billion in 2024.
- Across the five-year window, Enterprise Value surged 42.87% in 2023 and decreased 23.3% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$3.6 billion in 2022, then jumped by 42.87% to -$2.0 billion in 2023, then increased by 2.93% to -$2.0 billion in 2024, then dropped by 23.3% to -$2.4 billion in 2025, then gained by 20.78% to -$1.9 billion in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$1.9 billion in Q1 2026, -$2.4 billion in Q4 2025, and -$2.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -2.15 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | -3.97 Mn |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -153.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.94 Bn |
| Dec 31, 2025 | -2.45 Bn |
| Sep 30, 2025 | -2.08 Bn |
| Jun 30, 2025 | -1.44 Bn |
| Mar 31, 2025 | -1.72 Bn |
| Dec 31, 2024 | -1.99 Bn |
| Sep 30, 2024 | -1.71 Bn |
| Jun 30, 2024 | -1.58 Bn |
| Mar 31, 2024 | -1.98 Bn |
| Dec 31, 2023 | -2.05 Bn |
| Sep 30, 2023 | -1.76 Bn |
| Jun 30, 2023 | -1.72 Bn |
| Mar 31, 2023 | -2.11 Bn |
| Dec 31, 2022 | -3.58 Bn |
| Sep 30, 2022 | -2.51 Bn |
| Jun 30, 2022 | -2.65 Bn |
| Mar 31, 2022 | -3.14 Bn |
| Dec 31, 2021 | -3.48 Bn |
| Sep 30, 2021 | -3.27 Bn |
| Jun 30, 2021 | -3.66 Bn |